lanthanum has been researched along with Hyperparathyroidism in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Akizawa, T; Fukagawa, M; Fukushima, M; Hirakata, H; Kagimura, T; Ogata, H | 1 |
Bacchetta, J; Cochat, P; Morel, Y; Nicolino, M; Plotton, I; Ranchin, B; Vial, T | 1 |
Rees, L; Shroff, RC | 1 |
Albaaj, F; Hutchison, A | 1 |
2 review(s) available for lanthanum and Hyperparathyroidism
Article | Year |
---|---|
Phosphate binders in CKD: chalking out the differences.
Topics: Calcium; Calcium Carbonate; Child; Diet; Humans; Hyperparathyroidism; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Phosphates; Polyamines; Renal Dialysis; Sevelamer; Vascular Diseases | 2010 |
Hyperphosphataemia in renal failure: causes, consequences and current management.
Topics: Aluminum; Calcinosis; Calcitriol; Calcium; Cardiovascular Diseases; Chlorides; Epoxy Compounds; Humans; Hyperparathyroidism; Kidney Failure, Chronic; Lanthanum; Magnesium; Phosphates; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer; Uronic Acids; Zirconium | 2003 |
1 trial(s) available for lanthanum and Hyperparathyroidism
Article | Year |
---|---|
Effect of Treating Hyperphosphatemia With Lanthanum Carbonate vs Calcium Carbonate on Cardiovascular Events in Patients With Chronic Kidney Disease Undergoing Hemodialysis: The LANDMARK Randomized Clinical Trial.
Topics: Aged; Calcium Carbonate; Cardiovascular Diseases; Female; Heart Disease Risk Factors; Hip Fractures; Humans; Hyperparathyroidism; Hyperphosphatemia; Incidence; Japan; Lanthanum; Male; Phosphates; Renal Dialysis; Renal Insufficiency, Chronic; Survival Analysis; Vascular Calcification | 2021 |
1 other study(ies) available for lanthanum and Hyperparathyroidism
Article | Year |
---|---|
Precocious puberty and unlicensed paediatric drugs for severe hyperparathyroidism.
Topics: Child, Preschool; Cinacalcet; Drug Approval; Drug Labeling; Hepatocyte Nuclear Factor 1-beta; Humans; Hyperparathyroidism; Kidney Failure, Chronic; Lanthanum; Male; Mutation; Naphthalenes; Puberty, Precocious; Testosterone; Treatment Outcome | 2009 |